Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

(HealthDay)—For patients with rheumatoid arthritis (RA), there are common risk factors for venous thromboembolism (VTE) and atherosclerotic cardiovascular disease (ASCVD), and the risk for ASCVD is in

Updated on: June 01,2024

Risk factors ID'd for VTE, ASCVD in rheumatoid arthritis patients

(HealthDay)—For patients with rheumatoid arthritis (RA), there are common risk factors for venous thromboembolism (VTE) and atherosclerotic cardiovascular disease (ASCVD), and the risk for ASCVD is in

Updated on:June 01,2024

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

by La Jolla Institute for ImmunologyA multi-layered, virus-specific immune response is important for controlling the virus during the acute phase of the infection and reducing COVID-19 disease se

Updated on: April 24,2024

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

by La Jolla Institute for ImmunologyA multi-layered, virus-specific immune response is important for controlling the virus during the acute phase of the infection and reducing COVID-19 disease se

Updated on:April 24,2024

Black patients with RA less likely to receive biologics, more likely to get glucocorticoids

by American College of RheumatologyCredit: CC0 Public DomainA new study reveals that Black patients with rheumatoid arthritis (RA) were less likely to be prescribed a biologic treatment and more

Updated on: July 02,2024

Black patients with RA less likely to receive biologics, more likely to get glucocorticoids

by American College of RheumatologyCredit: CC0 Public DomainA new study reveals that Black patients with rheumatoid arthritis (RA) were less likely to be prescribed a biologic treatment and more

Updated on:July 02,2024

Study finds half of patients with low-grade proteinuria develop treatable lupus nephritis within two years

by American College of RheumatologyCredit: Short- and Long-Term Progression of Kidney Involvement in Systemic Lupus Erythematosus Patients with Low-Grade Proteinuria (2022) https://acrabstracts.o

Updated on: May 08,2024

Study finds half of patients with low-grade proteinuria develop treatable lupus nephritis within two years

by American College of RheumatologyCredit: Short- and Long-Term Progression of Kidney Involvement in Systemic Lupus Erythematosus Patients with Low-Grade Proteinuria (2022) https://acrabstracts.o

Updated on:May 08,2024

Decline in risk of dementia and heart failure in patients with rheumatoid arthritis

by European Alliance of Associations for RheumatologyCredit: CC0 Public DomainRheumatoid arthritis (RA) is an inflammatory autoimmune disease that causes pain, swelling and stiffness in the joints. It

Updated on: May 08,2024

Decline in risk of dementia and heart failure in patients with rheumatoid arthritis

by European Alliance of Associations for RheumatologyCredit: CC0 Public DomainRheumatoid arthritis (RA) is an inflammatory autoimmune disease that causes pain, swelling and stiffness in the joints. It

Updated on:May 08,2024

Chemical stimuli can support growing of stable cartilage cells

by Umea UniversityRho-kinase inhibition cause disappearance of cellular adhesion sites. The colors of the figure shows the staining for actin stress fibers (red), adhesion plaques-related vinculi

Updated on: May 08,2024

Chemical stimuli can support growing of stable cartilage cells

by Umea UniversityRho-kinase inhibition cause disappearance of cellular adhesion sites. The colors of the figure shows the staining for actin stress fibers (red), adhesion plaques-related vinculi

Updated on:May 08,2024

Major savings possible with app-based osteoarthritis treatment

by Lund UniversityCredit: CC0 Public DomainOsteoarthritis treatment conducted digitally via an app costs around 25% of what conventional care costs, according to a study from Lund University in S

Updated on: April 17,2024

Major savings possible with app-based osteoarthritis treatment

by Lund UniversityCredit: CC0 Public DomainOsteoarthritis treatment conducted digitally via an app costs around 25% of what conventional care costs, according to a study from Lund University in S

Updated on:April 17,2024

How B cells recognize new variants of SARS-CoV-2

by Dr. Jan Grabowski, TWINCORE - Zentrum für Experimentelle und Klinische InfektionsforschungThe first author of the study, Dr Matthias Bruhn, in the lab Credit: TWINCORE/GrabowskiB cells are part of

Updated on: April 28,2024

How B cells recognize new variants of SARS-CoV-2

by Dr. Jan Grabowski, TWINCORE - Zentrum für Experimentelle und Klinische InfektionsforschungThe first author of the study, Dr Matthias Bruhn, in the lab Credit: TWINCORE/GrabowskiB cells are part of

Updated on:April 28,2024

Delivery methods compared for osteoarthritis intervention

First-line intervention for hip or knee osteoarthritis (OA) may reduce pain whether delivered in-person or digitally, according to a study published online Nov. 3 inJAMA Network Open.Therese Jön

Updated on: May 29,2024

Delivery methods compared for osteoarthritis intervention

First-line intervention for hip or knee osteoarthritis (OA) may reduce pain whether delivered in-person or digitally, according to a study published online Nov. 3 inJAMA Network Open.Therese Jön

Updated on:May 29,2024

Versatile antibody technology allows design of long-acting antibodies with tailored target-dependent mode of actions

by University of OsloREW enhances phagocytosis of gram-positive and killing of gram-negative bacteria. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-46321-9Antibody ther

Updated on: March 19,2024

Versatile antibody technology allows design of long-acting antibodies with tailored target-dependent mode of actions

by University of OsloREW enhances phagocytosis of gram-positive and killing of gram-negative bacteria. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-46321-9Antibody ther

Updated on:March 19,2024

Risankizumab safe, effective at 52 weeks for psoriatic arthritis

by Lori SolomonRisankizumab provides long-term benefits in patients with psoriatic arthritis (PsA) who have not achieved adequate response to previous therapies, according to a study recently publishe

Updated on: June 01,2024

Risankizumab safe, effective at 52 weeks for psoriatic arthritis

by Lori SolomonRisankizumab provides long-term benefits in patients with psoriatic arthritis (PsA) who have not achieved adequate response to previous therapies, according to a study recently publishe

Updated on:June 01,2024

Osteoarthritis: Carbohydrate-binding protein promotes inflammation

by Medical University of ViennaFunction and effect of galectin-1 in osteoarthritis identified for the very first timeMore and more people, particularly older people, are suffering from osteoarthr

Updated on: March 24,2024

Osteoarthritis: Carbohydrate-binding protein promotes inflammation

by Medical University of ViennaFunction and effect of galectin-1 in osteoarthritis identified for the very first timeMore and more people, particularly older people, are suffering from osteoarthr

Updated on:March 24,2024